What is the address of Dr. Van Steenweghen - Dr. Verstraete?

The registered office of Dr. Van Steenweghen - Dr. Verstraete is located at Doornstraat 31, 2270 Herenthout.

Is Dr. Van Steenweghen - Dr. Verstraete still active?

Yes. According to the CBE (16 September 2026) Dr. Van Steenweghen - Dr. Verstraete is active, legal situation “Normale toestand”, started on 15 July 2004.

Is Dr. Van Steenweghen - Dr. Verstraete registered on Peppol?

Yes, Dr. Van Steenweghen - Dr. Verstraete is registered on the Peppol network with ID 0208:0866370148.

What is the enterprise number of Dr. Van Steenweghen - Dr. Verstraete?

The enterprise number of Dr. Van Steenweghen - Dr. Verstraete is BE0866370148.

When was Dr. Van Steenweghen - Dr. Verstraete founded?

Dr. Van Steenweghen - Dr. Verstraete was founded on 15 July 2004.

Who are the directors of Dr. Van Steenweghen - Dr. Verstraete?

According to the 2025 annual accounts, the directors of Dr. Van Steenweghen - Dr. Verstraete are: Steven Van Steenweghen, Lieve Verstraete.

Is Dr. Van Steenweghen - Dr. Verstraete a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 July 2004; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Dr. Van Steenweghen - Dr. Verstraete make in 2025?

Dr. Van Steenweghen - Dr. Verstraete posted a profit after taxes of € 103,565 in financial year 2025.

What is the revenue of Dr. Van Steenweghen - Dr. Verstraete?

As a small company, Dr. Van Steenweghen - Dr. Verstraete is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 163,422.

Dr. Van Steenweghen - Dr. Verstraete (Private Limited)

Dossier Dr. Van Steenweghen - Dr. Verstraete, printed on 16 September 2026 from databakkes.be/en/0866370148/dr-van-steenweghen-dr-verstraete. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Van Steenweghen - Dr. Verstraete from Herenthout, company number BE0866370148, closed financial year 2025 with a result of € 103,565 after tax. For that financial year Dr. Van Steenweghen - Dr. Verstraete recorded a gross margin of € 163,422 and equity of € 489,763. Compared with financial year 2024, the result moved from € 98,504 to € 103,565. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 28, 2026.

What it is worth Growing

€ 489,763

▲ 21% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 103,565

▲ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 247,330

▲ 30% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 19,771 paid out

19 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 43,892

▲ 201% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 870

▼ 92% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 8,211

▼ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 17,614

▲ 9% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 123,781 Gross margin 2022: € 123,781 First fiscal year in the series	€ 85,574 Gross margin 2023: € 85,574 ▼ 31% vs 2022 (€ 123,781) Unfavourable step	€ 155,157 Gross margin 2024: € 155,157 ▲ 81% vs 2023 (€ 85,574) Favourable step	€ 163,422 Gross margin 2025: € 163,422 ▲ 5% vs 2024 (€ 155,157) Favourable step	▲ 5%
Profit after taxes	€ 76,045 Profit after taxes 2022: € 76,045 First fiscal year in the series	€ 49,117 Profit after taxes 2023: € 49,117 ▼ 35% vs 2022 (€ 76,045) Unfavourable step	€ 98,504 Profit after taxes 2024: € 98,504 ▲ 101% vs 2023 (€ 49,117) Favourable step	€ 103,565 Profit after taxes 2025: € 103,565 ▲ 5% vs 2024 (€ 98,504) Favourable step	▲ 5%
Equity	€ 277,548 Equity 2022: € 277,548 First fiscal year in the series	€ 325,065 Equity 2023: € 325,065 ▲ 17% vs 2022 (€ 277,548) Favourable step	€ 405,970 Equity 2024: € 405,970 ▲ 25% vs 2023 (€ 325,065) Favourable step	€ 489,763 Equity 2025: € 489,763 ▲ 21% vs 2024 (€ 405,970) Favourable step	▲ 21%
Total debts	€ 58,671 Total debts 2022: € 58,671 First fiscal year in the series	€ 26,100 Total debts 2023: € 26,100 ▼ 56% vs 2022 (€ 58,671) Favourable step	€ 40,090 Total debts 2024: € 40,090 ▲ 54% vs 2023 (€ 26,100) Unfavourable step	€ 33,280 Total debts 2025: € 33,280 ▼ 17% vs 2024 (€ 40,090) Favourable step	▼ 17%
Cash	€ 154,083 Cash 2022: € 154,083 First fiscal year in the series	€ 188,961 Cash 2023: € 188,961 ▲ 23% vs 2022 (€ 154,083) Favourable step	€ 189,796 Cash 2024: € 189,796 Unchanged (€ 188,961) Favourable step	€ 247,330 Cash 2025: € 247,330 ▲ 30% vs 2024 (€ 189,796) Favourable step	▲ 30%
Land & buildings	€ 13,114 Land & buildings 2022: € 13,114 First fiscal year in the series	€ 11,096 Land & buildings 2023: € 11,096 ▼ 15% vs 2022 (€ 13,114) Unchanged	€ 9,078 Land & buildings 2024: € 9,078 ▼ 18% vs 2023 (€ 11,096) Unchanged	€ 7,060 Land & buildings 2025: € 7,060 ▼ 22% vs 2024 (€ 9,078) Unchanged	▼ 22%
Retained profit	€ 258,948 Retained profit 2022: € 258,948 First fiscal year in the series	€ 306,465 Retained profit 2023: € 306,465 ▲ 18% vs 2022 (€ 258,948) Favourable step	€ 387,370 Retained profit 2024: € 387,370 ▲ 26% vs 2023 (€ 306,465) Favourable step	€ 471,163 Retained profit 2025: € 471,163 ▲ 22% vs 2024 (€ 387,370) Favourable step	▲ 22%
Dividend	€ 1,600 Dividend 2022: € 1,600 First fiscal year in the series	€ 1,600 Dividend 2023: € 1,600 Unchanged (€ 1,600) Unchanged	€ 17,600 Dividend 2024: € 17,600 ▲ € 16,000 vs 2023 (€ 1,600) Unchanged	€ 19,771 Dividend 2025: € 19,771 ▲ 12% vs 2024 (€ 17,600) Unchanged	▲ 12%
Bank debt	€ 31,488 Bank debt 2022: € 31,488 First fiscal year in the series	€ 21,433 Bank debt 2023: € 21,433 ▼ 32% vs 2022 (€ 31,488) Favourable step	€ 11,227 Bank debt 2024: € 11,227 ▼ 48% vs 2023 (€ 21,433) Favourable step	€ 870 Bank debt 2025: € 870 ▼ 92% vs 2024 (€ 11,227) Favourable step	▼ 92%
Balance sheet total	€ 336,219 Balance sheet total 2022: € 336,219 First fiscal year in the series	€ 351,165 Balance sheet total 2023: € 351,165 ▲ 4% vs 2022 (€ 336,219) Unchanged	€ 446,059 Balance sheet total 2024: € 446,059 ▲ 27% vs 2023 (€ 351,165) Unchanged	€ 523,043 Balance sheet total 2025: € 523,043 ▲ 17% vs 2024 (€ 446,059) Unchanged	▲ 17%

Key figures of Dr. Van Steenweghen - Dr. Verstraete, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to Dr. Van Steenweghen - Dr. Verstraete?

What happened at Dr. Van Steenweghen - Dr. Verstraete in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 28, 2026 New annual accounts for financial year 2025: profit of € 103,565 (▲ 5% vs 2024). Source: NBB ↗
Oct 1, 2024 New establishment in Herenthout. KBO
2023 Steven Van Steenweghen became a director. NBB
2023 Lieve Verstraete became a director. NBB
Jul 15, 2004 Start of the company according to the CBE. KBO

In short

From € 76,045 profit in 2022 to € 103,565 profit in 2025.

Paid € 131,058 in corporate taxes since 2022.

Best year ever: 2025, with € 103,565 profit.

Paid out € 40,571 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Van Steenweghen - Dr. Verstraete? We notify you, reason included.

Follow Dr. Van Steenweghen - Dr. Verstraete

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Steven Van Steenweghen Lieve Verstraete

Dr. Van Steenweghen - Dr. Verstraete

Behind Dr. Van Steenweghen - Dr. Verstraete are Steven Van Steenweghen and Lieve Verstraete.

See the full network in the app

Directors

According to the 2025 annual accounts

Steven Van Steenweghen

Director

since 2023

Lieve Verstraete

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Doornstraat 31

2270 Herenthout

2.371.012.669

Molenstraat 25 box 2

2270 Herenthout

Active since 1 October 2024

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0866.370.148
VAT number: BE 0866.370.148
Registered office: Doornstraat 31, 2270 Herenthout
Names & denominations: Dr. Van Steenweghen - Dr. Verstraete
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 15 July 2004
Peppol: Active · Active since 30 Nov 2024

View on CBE Public ↗ Annual accounts (NBB) ↗